As Lorbas said in his response to you, CYDY report

Quote:

---

As Lorbas said in his response to you, CYDY reported 120 patients in the severe trial as of July 1st, 2020. Given that number, I suspect that more than 79, as you estimated, we’re enrolled as of June 25th. The number may be closer to 100, but we won’t know until the data is releaed.

---

I had somehow forgotten that disclosure. Yes, might be around 100. And CytoDyn's numbers might benefit from having some percentage of those additional 31 patients above #69 possibly having been admitted in an (unfortunately) intubated state. And I absolutely don't mean that in an insensitive way.

Quote:

---

Second questions: I’m assuming the safety analysis of the severe trial will only show how many patients have died in the placebo arm vs leronlimab arm?

---

I would hope that they are processing a progressive analysis of the other endpoints as patients finish Day 28, including Dr.BP's companion assays which we know are being performed, but which are not technically included in the trial protocol.